Skip to main content
. 2022 Jan 12;8:793515. doi: 10.3389/fmed.2021.793515

Figure 3.

Figure 3

Prognostic analysis of pyroptosis-related lncRNA signature in the training and validation cohorts. (A) Distribution of risk scores in the training cohort. (B) Distribution of risk scores in the validation cohort. (C) Distributions of overall survival status, overall survival, and risk score in the training cohort. (D) Distributions of overall survival status, overall survival, and risk score in the validation cohort. (E) Kaplan-Meier curves for the overall survival of patients in the high- and low-risk groups in the training cohort. (F) Kaplan-Meier curves for the overall survival of patients in the high- and low-risk groups in the validation cohort. (G) AUC of time-dependent ROC curves verified the prognostic accuracy of the risk score in the training cohort. (H) AUC of time-dependent ROC curves verified the prognostic accuracy of the risk score in the validation cohort. (I) Kaplan-Meier curves for the overall survival of patients in the high- and low-risk groups in the whole cohort.